tiprankstipranks
Advertisement
Advertisement

Predict and Weatecho Launch Hospital 4.0 Robotics Network to Digitize Hospital Operations

Story Highlights
  • Predict signs a 24-month network contract with Weatecho to create a Hospital 4.0 collaborative robotics ecosystem for public and private hospitals.
  • The partnership combines Predict’s social robotics and AI with Weatecho’s logistics robotics to digitize hospital processes, enhancing efficiency, safety and patient experience.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Predict and Weatecho Launch Hospital 4.0 Robotics Network to Digitize Hospital Operations

Claim 55% Off TipRanks

Predict S.P.A. Class B ( (IT:PRE) ) just unveiled an announcement.

Predict S.p.A. has signed a 24‑month network contract with Weatecho S.r.l., a Politecnico di Bari spin‑off specialized in nanotechnologies and advanced sensors, to build a Hospital 4.0 collaborative robotics ecosystem aimed at improving efficiency, safety and patient experience in public and private hospitals. By combining Predict’s social robotics and AI capabilities, including its Aphel robotic platform, with Weatecho’s Flash Bot logistics robot and Industry 4.0 expertise, the partners plan to digitize and automate key hospital functions—welcome and patient guidance, secure logistics of clinical samples and drugs, and laboratory sample management—creating a data‑driven environment where AI analyzes real‑time sensor and process data to identify inefficiencies and enhance care quality, while allowing additional partners to join the network and potentially strengthening Predict’s positioning at the intersection of robotics, healthcare digitalization and hospital process automation.

The most recent analyst rating on (IT:PRE) stock is a Buy with a EUR1.45 price target. To see the full list of analyst forecasts on Predict S.P.A. Class B stock, see the IT:PRE Stock Forecast page.

More about Predict S.P.A. Class B

Predict S.p.A., founded in 2008 in Bari, is an Italian innovative SME in the med‑tech sector focused on in vivo diagnostics, breath-analysis technologies and digital healthcare. Through four strategic business units, it distributes ultrasound and radiological imaging equipment, develops non‑invasive diagnostic systems such as its Mistral breath-analysis platform, and offers augmented reality and robotics solutions like its Aphel social robotics and Optip holopresence systems for hospitals, clinics and medical professionals, supported by partnerships with leading Italian university hospitals and research institutes.

Average Trading Volume: 27,000

Technical Sentiment Signal: Strong Buy

Current Market Cap: €6.29M

Learn more about PRE stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1